Scheriproct–Salbe
Recall
|
Medicines
|
15/03/2012
The marketing authorization holder informed its supplied customers in a letter dated March 15, 2012, that a degradation product of the active ingredient cinchocaine hydrochloride exceeded the specification limit during the period of use and that a recall must therefore be carried out.
| Name of the medicinal product | Scheriproct – Salbe 30g |
|---|---|
| Marketing authorisation number(s) | 10260 |
| Marketing authorisation holder | Bayer Austria GmbH |
| Batch number(s) | 94081A, 02108A, 11149B, 13174C |
| Expiry date | 09/04/2019 |
| Classification of the recall | 2 |
| BASG reference number | INS-640.001-0385 |
Further inquiry note
Page last modified:
12/07/2022